- Home
- SNGX vs SOAR Comparison
SNGX vs SOAR Comparison
Compare SNGX & SOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- SOAR
- Stock Information
- Founded
- SNGX 1987
- SOAR 2021
- Country
- SNGX United States
- SOAR United States
- Employees
- SNGX N/A
- SOAR N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- SOAR Blank Checks
- Sector
- SNGX Health Care
- SOAR Finance
- Exchange
- SNGX Nasdaq
- SOAR Nasdaq
- Market Cap
- SNGX 13.8M
- SOAR 15.7M
- IPO Year
- SNGX 1987
- SOAR N/A
- Fundamental
- Price
- SNGX $1.48
- SOAR $1.17
- Analyst Decision
- SNGX Strong Buy
- SOAR
- Analyst Count
- SNGX 1
- SOAR 0
- Target Price
- SNGX $6.00
- SOAR N/A
- AVG Volume (30 Days)
- SNGX 256.3K
- SOAR 332.4K
- Earning Date
- SNGX 11-07-2025
- SOAR 11-13-2025
- Dividend Yield
- SNGX N/A
- SOAR N/A
- EPS Growth
- SNGX N/A
- SOAR N/A
- EPS
- SNGX N/A
- SOAR 2.32
- Revenue
- SNGX N/A
- SOAR $58,312,000.00
- Revenue This Year
- SNGX N/A
- SOAR N/A
- Revenue Next Year
- SNGX N/A
- SOAR N/A
- P/E Ratio
- SNGX N/A
- SOAR $0.92
- Revenue Growth
- SNGX N/A
- SOAR N/A
- 52 Week Low
- SNGX $1.09
- SOAR $1.02
- 52 Week High
- SNGX $6.23
- SOAR $11.41
- Technical
- Relative Strength Index (RSI)
- SNGX 47.15
- SOAR 38.06
- Support Level
- SNGX $1.25
- SOAR $1.04
- Resistance Level
- SNGX $1.47
- SOAR $1.24
- Average True Range (ATR)
- SNGX 0.11
- SOAR 0.16
- MACD
- SNGX 0.02
- SOAR -0.02
- Stochastic Oscillator
- SNGX 65.45
- SOAR 26.04
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About SOAR Volato Group Inc.
Volato Group Inc operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.